Inhibition of the histone H3-ASF1 (anti-silencing function 1) protein-protein interaction (PPI) represents a potential approach for treatment of numerous cancers. As an α-helix mediated PPI, constraint of the key histone H3 helix (residues 118-135) represents a strategy through which chemical probes might be elaborated to test this hypothesis. In this work variant H3118-135 peptides bearing pentenyl glycine residues at i and i + 4 positions were constrained by olefin metathesis. Biophysical analyses revealed that promotion of a bioactive helical conformation depends on the position at which the constraint is introduced, but that potency of binding towards ASF1 is unaffected by the constraint and instead that enthalpy-entropy compensation oc...
18 pags., 4 figs., 5 tabs. -- This article belongs to the Special Issue Folding and Design of α-Heli...
Intracellular regulatory pathways are replete with protein-protein and protein-DNA interactions, off...
Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural sta...
International audienceInhibiting the histone H3-ASF1 (anti-silencing function 1) protein-protein int...
The cover feature picture shows how inhibition of the histone H3‐ASF1 (anti‐silencing function 1) pr...
The development of constrained peptides represents an emerging strategy to generate peptide based pr...
International audienceAnti-silencing function 1 (ASF1) is a conserved H3-H4 histone chaperone involv...
International audienceAnti-silencing function 1 (ASF1) is a conserved H3-H4 histone chaperone involv...
Protein–protein interactions (PPIs) control virtually all cellular processes and have thus emerged a...
Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportun...
Targeting PPIs with small molecules can be challenging owing to large, hydrophobic binding surfaces....
ASF1 est un chaperon d’histones H3-H4 impliqué dans de nombreux cancers. Comme bon nombre de protéin...
The targeting of protein–protein interactions (PPIs) that include secondary structure motifs such as...
In 2015, 8.8 million of death were due to cancer making it an important cause of death in the world....
?-Helices are common secondary structural elements forming key parts of the large, generally feature...
18 pags., 4 figs., 5 tabs. -- This article belongs to the Special Issue Folding and Design of α-Heli...
Intracellular regulatory pathways are replete with protein-protein and protein-DNA interactions, off...
Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural sta...
International audienceInhibiting the histone H3-ASF1 (anti-silencing function 1) protein-protein int...
The cover feature picture shows how inhibition of the histone H3‐ASF1 (anti‐silencing function 1) pr...
The development of constrained peptides represents an emerging strategy to generate peptide based pr...
International audienceAnti-silencing function 1 (ASF1) is a conserved H3-H4 histone chaperone involv...
International audienceAnti-silencing function 1 (ASF1) is a conserved H3-H4 histone chaperone involv...
Protein–protein interactions (PPIs) control virtually all cellular processes and have thus emerged a...
Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportun...
Targeting PPIs with small molecules can be challenging owing to large, hydrophobic binding surfaces....
ASF1 est un chaperon d’histones H3-H4 impliqué dans de nombreux cancers. Comme bon nombre de protéin...
The targeting of protein–protein interactions (PPIs) that include secondary structure motifs such as...
In 2015, 8.8 million of death were due to cancer making it an important cause of death in the world....
?-Helices are common secondary structural elements forming key parts of the large, generally feature...
18 pags., 4 figs., 5 tabs. -- This article belongs to the Special Issue Folding and Design of α-Heli...
Intracellular regulatory pathways are replete with protein-protein and protein-DNA interactions, off...
Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural sta...